Association of pre-diagnosis specific color groups of fruit and vegetable intake with ovarian cancer survival: results from the ovarian cancer follow-up study (OOPS)

被引:0
|
作者
Liu, Yu-Yang [1 ,2 ,3 ]
Gong, Ting-Ting [4 ]
Li, Yi-Zi [1 ,2 ,3 ]
Xu, He-Li [1 ,2 ,3 ]
Zheng, Gang [1 ,2 ,3 ]
Liu, Fang-Hua [1 ,2 ,3 ]
Qin, Xue [4 ]
Xiao, Qian [1 ,4 ]
Wu, Qi-Jun [1 ,2 ,3 ,5 ]
Huang, Dong-Hui [1 ,2 ,3 ]
Gao, Song [4 ]
Zhao, Yu-Hong [1 ,2 ,3 ]
机构
[1] China Med Univ, Dept Clin Epidemiol, Shengjing Hosp, 36 Sanhao St, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Clin Res Ctr, Shengjing Hosp, Shenyang, Peoples R China
[3] China Med Univ, Liaoning Key Lab Precis Med Res Major Chron Dis, Shengjing Hosp, Shenyang, Peoples R China
[4] China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, 36 Sanhao St, Shenyang 110001, Liaoning, Peoples R China
[5] China Med Univ, Natl Hlth Commiss, Key Lab Reprod & Genet Med, Shenyang, Peoples R China
基金
奥地利科学基金会;
关键词
10-YEAR INCIDENCE; CONSUMPTION; ADULTS; CELLS; RISK;
D O I
10.1039/d3fo01443f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The colors of fruits and vegetables (FV) reflect the presence of pigmented bioactive compounds. The evidence of pre-diagnosis specific FV color group intake contributing to ovarian cancer (OC) survival is limited and inconsistent. Methods: A prospective cohort study was conducted between 2015 and 2020 with 700 newly diagnosed OC patients. Pre-diagnosis dietary information was assessed by a validated food frequency questionnaire. We classified FV into five groups based on the color of their edible parts (e.g., green, red/purple, orange/yellow, white, and uncategorized groups). Cox proportional hazard models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association of specific color groups of FV before diagnosis with OC survival. Potential multiplicative and additive interactions were assessed. Results: 130 patients died during a median follow-up of 37.57 (interquartile: 24.77-50.20) months. We observed the improved survival with a higher pre-diagnosis intake of total FV (HRtertile 3 vs. tertile 1 = 0.63, 95%CI = 0.40-0.99), total vegetables (HRtertile 3 vs. tertile 1 = 0.57, 95%CI = 0.36-0.90), and red/purple FV (HRtertile 3 vs. tertile 1 = 0.52, 95%CI = 0.33-0.82). In addition, we observed significant dose-response relationships for per standard deviation increment between total vegetable intake (HR = 0.79, 95%CI = 0.65-0.96) and red/purple group intake (HR = 0.77, 95%CI = 0.60-0.99) before diagnosis with OC survival. Additionally, pre-diagnosis green FV intake was borderline associated with better OC survival (HRper standard deviation increment = 0.83; 95%CI = 0.69-1.00). In contrast, we did not observe significant associations between pre-diagnosis intake of total fruits, orange/yellow, white, and uncategorized groups and OC survival. Conclusion: Pre-diagnosis FV intake from various color groups, especially the green and red/purple ones, may improve OC survival. Further studies are needed to validate our findings. Pre-diagnosis fruit and vegetable intake from various color groups, especially the green and red/purple ones, may improve OC survival.
引用
收藏
页码:8442 / 8452
页数:11
相关论文
共 50 条
  • [21] PRE-DIAGNOSIS USE OF MENOPAUSAL HORMONE THERAPY ASSOCIATED WITH BETTER OVARIAN CANCER SURVIVAL
    Lee, Alice W.
    Peterson, Siri
    Wiensch, Ashley
    Pike, Malcolm C.
    Pearce, Celeste L.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 50 - 50
  • [22] Relationship between different forms of dietary choline and ovarian cancer survival: findings from the ovarian cancer follow-up study, a prospective cohort study
    Yang, Hui-Juan
    Kang, Ye
    Li, Yi-Zi
    Liu, Fang-Hua
    Yan, Shi
    Gao, Song
    Huo, Yun-Long
    Gong, Ting-Ting
    Wu, Qi-Jun
    FOOD & FUNCTION, 2022, 13 (23) : 12342 - 12352
  • [23] Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
    Nagle, C. M.
    Dixon, S. C.
    Jensen, A.
    Kjaer, S. K.
    Modugno, F.
    deFazio, A.
    Fereday, S.
    Hung, J.
    Johnatty, S. E.
    Fasching, P. A.
    Beckmann, M. W.
    Lambrechts, D.
    Vergote, I.
    Van Nieuwenhuysen, E.
    Lambrechts, S.
    Risch, H. A.
    Rossing, M. A.
    Doherty, J. A.
    Wicklund, K. G.
    Chang-Claude, J.
    Goodman, M. T.
    Ness, R. B.
    Moysich, K.
    Heitz, F.
    du Bois, A.
    Harter, P.
    Schwaab, I.
    Matsuo, K.
    Hosono, S.
    Goode, E. L.
    Vierkant, R. A.
    Larson, M. C.
    Fridley, B. L.
    Hogdall, C.
    Schildkraut, J. M.
    Weber, R. P.
    Cramer, D. W.
    Terry, K. L.
    Bandera, E. V.
    Paddock, L.
    Rodriguez-Rodriguez, L.
    Wentzensen, N.
    Yang, H. P.
    Brinton, L. A.
    Lissowska, J.
    Hogdall, E.
    Lundvall, L.
    Whittemore, A.
    McGuire, V.
    Sieh, W.
    BRITISH JOURNAL OF CANCER, 2015, 113 (05) : 817 - 826
  • [24] History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium
    Minlikeeva, Albina N.
    Freudenheim, Jo L.
    Eng, Kevin H.
    Cannioto, Rikki A.
    Friel, Grace
    Szender, J. Brian
    Segal, Brahm
    Odunsi, Kunle
    Mayor, Paul
    Diergaarde, Brenda
    Zsiros, Emese
    Kelemen, Linda E.
    Kobel, Martin
    Steed, Helen
    deFazio, Anna
    Jordan, Susan J.
    Fasching, Peter A.
    Beckmann, Matthias W.
    Risch, Harvey A.
    Rossing, Mary Anne
    Doherty, Jennifer A.
    Chang-Claude, Jenny
    Goodman, Marc T.
    Doerk, Thilo
    Edwards, Robert
    Modugno, Francesmary
    Ness, Roberta B.
    Matsuo, Keitaro
    Mizuno, Mika
    Karlan, Beth Y.
    Goode, Ellen L.
    Kjaer, Susanne K.
    Hogdall, Estrid
    Schildkraut, Joellen M.
    Terry, Kathryn L.
    Cramer, Daniel W.
    Bandera, Elisa V.
    Paddock, Lisa E.
    Kiemeney, Lambertus A.
    Massuger, Leon F. A. G.
    Sutphen, Rebecca
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Menon, Usha
    Gayther, Simon A.
    Ramus, Susan J.
    Gentry-Maharaj, Aleksandra
    Pearce, Celeste L.
    Wu, Anna H.
    Kupryjanczyk, Jolanta
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (09) : 1470 - 1473
  • [25] Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
    C M Nagle
    S C Dixon
    A Jensen
    S K Kjaer
    F Modugno
    A deFazio
    S Fereday
    J Hung
    S E Johnatty
    P A Fasching
    M W Beckmann
    D Lambrechts
    I Vergote
    E Van Nieuwenhuysen
    S Lambrechts
    H A Risch
    M A Rossing
    J A Doherty
    K G Wicklund
    J Chang-Claude
    M T Goodman
    R B Ness
    K Moysich
    F Heitz
    A du Bois
    P Harter
    I Schwaab
    K Matsuo
    S Hosono
    E L Goode
    R A Vierkant
    M C Larson
    B L Fridley
    C Høgdall
    J M Schildkraut
    R P Weber
    D W Cramer
    K L Terry
    E V Bandera
    L Paddock
    L Rodriguez-Rodriguez
    N Wentzensen
    H P Yang
    L A Brinton
    J Lissowska
    E Høgdall
    L Lundvall
    A Whittemore
    V McGuire
    W Sieh
    British Journal of Cancer, 2015, 113 : 817 - 826
  • [26] The value of mesothelin in the diagnosis and follow-up of surgically treated ovarian cancer
    Qiao, Naian
    Li, Haiying
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (02) : 163 - 165
  • [27] CASA and CA 125 in diagnosis and follow-up of advanced ovarian cancer
    Oehler, MK
    Sütterlin, M
    Caffier, H
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2513 - 2518
  • [28] Pre-diagnosis Dietary One-Carbon Metabolism Micronutrients Consumption and Ovarian Cancer Survival: A Prospective Cohort Study
    Xu, He-Li
    Gong, Ting-Ting
    Liu, Fang-Hua
    Wei, Yi-Fan
    Chen, Hong-Yu
    Yan, Shi
    Zhao, Yu-Hong
    Gao, Song
    Jiao, Yi-Sheng
    Wu, Qi-Jun
    FRONTIERS IN NUTRITION, 2022, 9
  • [29] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of ovarian cancer
    Vasey, PA
    ANNALS OF ONCOLOGY, 2001, 12 (09) : 1205 - 1207
  • [30] Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study
    Guleria, Sonia
    Jensen, Allan
    Toender, Anita
    Kjaer, Susanne K.
    CANCER CAUSES & CONTROL, 2020, 31 (01) : 25 - 31